Ironwood Pharmaceuticals
IRWD
$7.92
Share price
4.21%
Change (1 day)
-27.67%
Change (1 year)
Categories
Earnings for Ironwood Pharmaceuticals (IRWD)
Earnings in 2023 (TTM): -$0.95 B
According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.95 B. In 2022 the company made an earning of $0.25 B an increase over its 2021 earnings that were of $0.20 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Ironwood Pharmaceuticals from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.95 B | -475.59% |
| 2022 | $0.25 B | 25.8% |
| 2021 | $0.20 B | 84.32% |
| 2020 | $0.10 B | 84.69% |
| 2019 | $58.94 M | -125.13% |
| 2018 | -$0.24 B | 100.62% |
| 2017 | -$0.12 B | 43.12% |
| 2016 | -$81.71 M | -42.73% |
| 2015 | -$0.15 B | -24.76% |
| 2014 | -$0.19 B | -30.49% |
| 2013 | -$0.28 B | 275.65% |
| 2012 | -$72.63 M | 11.56% |
| 2011 | -$65.1 M | 9.38% |
| 2010 | -$59.52 M | -15.21% |
| 2009 | -$70.2 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 AstraZeneca AZN | $8.49 B | -996.03% | 🇬🇧 UK |
 Nektar Therapeutics
NKTR | -$0.28 B | -70.86% | 🇺🇸 USA |